Preeclampsia: An Obstetrician's Perspective

HE Guo-lin, LIU Xing-hui

Abstract

Preeclampsia-eclampsia is a common obstetric critical disease and obstetricians have studied it assiduously for hundreds of years. We have attempted to explore the etiology, pathology, prevention, intervention, and treatment of preeclampsia-eclampsia, but we still have not arrived at a thorough understanding of its causes, and it is difficult to find effective prevention and treatment methods. Although the research process has been fraught with difficulties and frustrations, we are nonetheless gradually gaining a better understanding of the disease. Perhaps, in the near future, we will be able to acquire a full understanding of the disease and find better ways to ensure the health and safety of mothers and fetuses.

 

Keywords: Preeclampsia, Eclampsia, Diagnosis, Prevention

 

Full Text:

PDF


References


BOISSIER DE SAUVAGES DE LACROIX F. Pathologia methodica. Montpellier: Martel， 1739.

CHESLEY L C. History and epidemiology of preeclampsia-eclampsia. Clin Obstet Gynecol，1984，27(4): 801–820.

BELL M J. A historical overview of preeclampsia-eclampsia. J Obstet Gynecol Neonatal Nurs，2010，39(5): 510–518.

DELEE J B. Theories of eclampsia. Am J Obstet，1905，51: 325–330.

LOUDON I. Some historical aspects of toxaemia of pregnancy. A review. Br J Obstet Gynaecol，1991，98(9): 853–858.

STANDER H J. The toxemias of pregnancy. Baltimore: The Williams & Wilkins Company， 1929.

ROBERTS J M， TAYLOR R N， MUSCI T J， et al. Preeclampsia:An endothelial cell disorder. Am J Obstet Gynecol，1989，161(5): 1200–1204.

CHESLEY L C. Hypertensive disorders in pregnancy. New York: Appleton-Century-Crofts， 1978.

PRITCHARD J A， MACDONALD P C. Williams obstetrics. 15th. New York: Appleton-Century-Crofts， 1976.

ACOG technical bulletin. Hypertension in pregnancy. Number 219-January 1996 (replaces no. 91, February 1986). Committee on Technical Bulletins of the American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet，1996，53(2): 175–183.

MAGEE L A， BROWN M A， HALL D R， et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification， diagnosis & management recommendations for international practice. Pregnancy Hypertens， 2022 ， 27: 148−169[2022-09-14]. https://pubmed. ncbi.nlm.nih.gov/35066406/. doi: 10.1016/j.preghy.2021.09.008. TSAKIRIDIS I， GIOULEKA S， ARVANITAKI A， et al. Gescational hypertension and preeclampsia : An overview of national and international gaidelines. Obstet Gynecol Surv，2021，76(10): 613–633.

JIM B， KARUMANCHI S A. Preeclampsia: Pathogenesis, prevention, and long-term complications. Semin Nephrol，2017，37(4): 386–397.

ROBILLARD P Y， DEKKER G， IACOBELLI S ， et al. An essay of reflection: why does preeclampsia exist in humans， and why are there such huge geographical differences in epidemiology? J Reprod Immunol， 2016， 114: 44−47[2022-09-14]. https://pubmed.ncbi.nlm.nih.gov/ 26253618/. doi: 10.1016/j.jri.2015.07.001.

GOODLIN R C， HAESSLEIN H O， FLEMING J. Aspirin for the treatment of recurrent toxaemia. Lancet， 1978， 2(8079): 51[2022-09-14]. https://pubmed.ncbi.nlm.nih.gov/78253/. doi: 10.1016/s0140-6736(78) 91367-3.

BROWN M A， MAGEE L A， KENNY L C， et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension，2018，72(1): 24–43.

POON L C， SHENNAN A， HYETT J A， et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet，2019，145 Suppl 1(Suppl 1): 1–33.

WEBSTER K， FISHBURN S， MARESH M， et al. Diagnosis and management of hypertension in pregnancy: Summary of updated NICE guidance. BMJ， 2019， 366: l5119[2022-09-14]. https://pubmed.ncbi.nlm. nih.gov/31501137/. doi: 10.1136/bmj.l5119.


Refbacks

  • There are currently no refbacks.